Trovagene declares activation of 2 supplementary Clinical Trial sites to conduct Phase 1b/2 Study Read more
Phase II CONDOR Trial suggests tolerance of inhibitor durvalumab in patients with metastatic head cancer Read more
Quidel seeks 510 (k) Clearance for QuickVue Influenza A+B Test complying FDA’s Class II RIDT Requirements Read more